文献速递心脑血管急症重症综合管理与镇静镇痛

中等收入国家动脉瘤性蛛网膜下腔出血患者临床特征与结局:前瞻性多中心研究

Clinical Characteristics and Outcomes of Patients with Aneurysmal Subarachnoid Hemorrhage: A Prospective Multicenter Study in a Middle-Income Country.
PubMed 文献 · Neurocrit Care · 2022-11-02
一句话结论巴西两中心471例动脉瘤性蛛网膜下腔出血患者6个月不良功能结局40%,迟诊、开颅夹闭为主,作者认为更早闭塞动脉瘤和增加血管内治疗可能改善结局。

该前瞻性研究纳入巴西两个参考中心2016年1月至2020年2月连续收治的471例成人动脉瘤性蛛网膜下腔出血患者,评估6个月改良Rankin量表功能结局。患者从症状出现到就诊中位时间4天,90%由非专科综合医院转诊,73%初始CT示厚层出血(改良Fisher评分3或4分),29%临床分级差(世界神经外科医师联盟评分4或5分)。66%行手术夹闭,25%行血管内栓塞,院内死亡率24%,40%患者6个月功能结局不良(改良Rankin量表评分4至6分)。多因素分析显示年龄、高血压、临床分级差、外引流、术后恶化、脑梗死、再出血和脓毒症与不良结局相关。作者结论认为巴西的动脉瘤性蛛网膜下腔出血管理与已发表队列和现行指南存在显著差异,更早闭塞动脉瘤和增加血管内治疗可能减少可改变的院内并发症并改善功能结局。

要点

  • 471例患者从症状出现到就诊中位时间4天(四分位距0-9天),90%(426例)由非专科综合医院转诊。
  • 73%患者初始CT示厚层出血(改良Fisher评分3或4分),29%(136例)临床分级差(世界神经外科医师联盟评分4或5分)。
  • 66%(312例)行手术夹闭,25%(119例)行血管内栓塞,仅7%(34例)在住院期间撤除或不予生命支持治疗。
  • 院内死亡率24%,40%(187例)患者6个月功能结局不良(改良Rankin量表评分4至6分)。
  • 不良结局相关因素:年龄(校正OR 1.05,95%CI 1.03-1.08)、高血压(校正OR 1.81,95%CI 1.04-3.16)、临床分级差(校正OR 4.92,95%CI 2.85-8.48)、外引流(校正OR 3.8,95%CI 2.31-6.24)、术后恶化(校正OR 2.33,95%CI 1.32-4.13)、脑梗死(校正OR 3.16,95%CI 1.81-5.52)、再出血(

适用人群与场景

  • 巴西两个参考中心连续收治的成人动脉瘤性蛛网膜下腔出血患者,纳入时间为2016年1月至2020年2月。

处置流程与药物剂量

  • 312例(66%)患者行手术夹闭动脉瘤。
  • 119例(25%)患者行血管内栓塞动脉瘤。
  • 34例(7%)患者在住院期间撤除或不予生命支持治疗。

研究设计与关键结果

  • 研究类型为前瞻性研究,纳入471例患者,来自巴西两个参考中心。
  • 从症状出现到就诊中位时间4天(四分位距0-9天),中位年龄55岁(四分位距46-62岁),女性353例(75%)。
  • 426例(90%)患者由非专科综合医院转诊。
  • 初始CT示厚层出血(改良Fisher评分3或4分)者占73%,临床分级差(世界神经外科医师联盟评分4或5分)者136例(29%)。
  • 312例(66%)行手术夹闭,119例(25%)行血管内栓塞,34例(7%)住院期间撤除或不予生命支持治疗。
  • 院内死亡率24%,187例(40%)患者6个月功能结局不良(改良Rankin量表评分4至6分)。
  • 多因素分析显示与不良结局相关的因素:年龄(校正OR 1.05,95%CI 1.03-1.08)、高血压(校正OR 1.81,95%CI 1.04-3.16)、临床分级差(校正OR 4.92,95%CI 2.85-8.48)、外引流(校正OR 3.8,95%CI 2.31-6.24)、术后恶化(校正OR 2.33,95%CI 1.32-4.13)、脑梗死(校正OR 3.16,95%CI 1.81-5.52)、再出血(校正OR 2.95,95%CI 1.13-7.69)、脓毒症(校正OR 2.68,95%CI 1.42-5.05)。

证据类型、等级与局限

  • 证据类型:前瞻性多中心研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,更早闭塞动脉瘤和增加血管内治疗的使用可能减少可改变的院内并发症并改善巴西的功能结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Aneurysmal subarachnoid hemorrhage (SAH) is associated with high mortality and long-term functional impairment. Data on clinical management and functional outcomes from developing countries are scarce. We aimed to define patient profiles and clinical practices and evaluate long-term outcomes after SAH in a middle-income country.

METHODS: This was a prospective study including consecutive adult patients admitted with SAH to two reference centers in Brazil from January 2016 to February 2020. The primary outcome was functional status at 6 months using the modified Rankin Scale. Mixed multivariable analysis was performed to determine the relationship between clinical variables and functional outcomes.

RESULTS: From 471patients analyzed, the median time from symptom onset to arrival at a study center was 4 days (interquartile range 0-9). Median age was 55 years (interquartile range 46-62) and 353 (75%) patients were women. A total of 426 patients (90%) were transferred from nonspecialized general hospitals, initial computed tomography revealed thick hemorrhage in 73% of patients (modified Fisher score of 3 or 4), and 136 (29%) had poor clinical grade (World Federation of Neurological Surgeons score of 4 or 5). A total of 312 (66%) patients underwent surgical clipping, and 119 (25%) underwent endovascular coiling. Only 34 patients (7%) underwent withdrawal or withholding of life-sustaining therapy during their hospital stay, and in-hospital mortality was 24%. A total of 187 (40%) patients had an unfavorable long-term functional outcome (modified Rankin Scale score of 4 to 6). Factors associated with unfavorable outcome were age (adjusted odds ratio [OR] 1.05, 95% confidence interval [CI] 1.03-1.08), hypertension (adjusted OR 1.81, 95% CI 1.04-3.16), poor clinical grade (adjusted OR 4.92, 95% CI 2.85-8.48), external ventricular drain (adjusted OR 3.8, 95% CI 2.31-6.24), postoperative deterioration (adjusted OR 2.33, 95% CI 1.32-4.13), cerebral infarction (adjusted OR 3.16, 95% CI 1.81-5.52), rebleeding (adjusted OR 2.95, 95% CI 1.13-7.69), and sepsis (adjusted OR 2.68, 95% CI 1.42-5.05).

CONCLUSIONS: Our study demonstrated that SAH management in a middle-income country diverges significantly from published cohorts and current guidelines, despite comparable clinical profiles on presentation and admission to high-volume referral centers. Earlier aneurysm occlusion and increased use of endovascular therapy could potentially reduce modifiable in-hospital complications and improve functional outcomes in Brazil.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Gonçalves B, Rynkowski C, Turon R, et al. Clinical Characteristics and Outcomes of Patients with Aneurysmal Subarachnoid Hemorrhage: A Prospective Multicenter Study in a Middle-Income Country. Neurocrit Care. 2022. PMID: 36324005. doi:10.1007/s12028-022-01629-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。